Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SNPX - Synaptogenix gets new Alzheimer's disease related patent


SNPX - Synaptogenix gets new Alzheimer's disease related patent

Synaptogenix ([[SNPX]] +1.7%) announces that a new patent has been awarded by the U.S. Patent and Trademark Office in relation to the treatment of Alzheimer's disease.Patent number 16/914,399 is entitled: Methods for Inducing Synaptogenesis with Synaptic Growth Factor Activating Compounds.The company also talked up the potential of its lead drug bryostatin in treating neurodegenerative diseases like Alzheimer's disease, Parkinson's disease and Multiple Sclerosis, among others.

For further details see:

Synaptogenix gets new Alzheimer's disease related patent
Stock Information

Company Name: Synaptogenix Inc.
Stock Symbol: SNPX
Market: OTC
Website: synaptogen.com

Menu

SNPX SNPX Quote SNPX Short SNPX News SNPX Articles SNPX Message Board
Get SNPX Alerts

News, Short Squeeze, Breakout and More Instantly...